The European Union and AstraZeneca reach a settlement to end a legal battle over slow delivery of the Oxford–AstraZeneca COVID-19 vaccine, with an agreement that requires AstraZeneca to deliver the remaining 200 million doses of its vaccine to the EU countries at the end of March 2022.